QUALITY & LABORATORY CAPABILITY
Quality review covers materials, formulation, production and documentation for each confirmed project scope.
Testing and documentation are reviewed in the context of the responsible facility, product and market.
QUALITY REVIEW
Laboratory review, production controls and destination-market requirements are considered throughout product development.
LABORATORY REVIEW
Applicable laboratory and quality-control activities are matched to the selected product, facility and project scope.
MARKET & COMPLIANCE
Ingredients, formula, label and supporting documents are reviewed against the requirements identified for the destination market.
PRODUCTION CONTROL
Manufacturing, inspection and supporting records are confirmed with the responsible facility for the agreed product scope.
QUALITY ASSURANCE
Every project follows a structured quality review process covering raw materials, production controls, testing and final batch release. Requirements are confirmed according to the product, manufacturing site and target market.
Certifications, testing scope and supporting documents vary by manufacturing site, product and project requirements.
01 — RAW MATERIALS
Raw materials are reviewed against agreed specifications, including identity, quality standards and required supporting documentation.
02 — PRODUCTION
Key manufacturing parameters are monitored throughout production to support consistency, safety and product quality.
03 — TESTING
Finished products are tested according to the agreed specification, which may include microbiological, heavy metal, active ingredient and other applicable quality checks.
04 — RELEASE
Production and testing records are reviewed before final batch release, with applicable quality documents provided for the project.
CHINA FACILITY DOCUMENTATION
These records relate to Nuspower Greatsun (Guangdong) Biotechnology Co., Ltd. at No. 1 Xingye Road, Mingzhu Industrial Park, Conghua, Guangzhou, China.
The supplied ISO 9001:2015 and ISO 22000:2018 certificates cover the named China facility and the food-production activities specified in each certificate. Document period: 4 December 2024 to 3 December 2027.
The supplied ISO 14001:2015 certificate covers environmental management for the food-production activities and related operations identified in the certificate. Document period: 4 December 2024 to 3 December 2027.
The supplied certificate references NSF/ANSI 455-2-2024. Its listed product categories are capsules, powders, soft gels and tablets at the named China facility. Document expiry: 11 November 2026.
The supplied certificate covers health-food powder and hard-capsule production and commissioned production in Solid No. 4 workshop. Document expiry: 16 October 2026.
CNAS L14115 names the facility’s Quality Inspection Department. The accompanying schedule lists specified microbiological, compositional and physicochemical tests, with method-specific limits. Schedule expiry: 23 December 2026.
The supplied file includes an export-food-manufacturer filing and a Halal certificate limited to five named FIVE DOCTORS products. Product-specific records are matched to the actual product and target market; the Halal scope does not cover the full catalogue.
The dates below are those shown in the supplied documents. Scope remains specific to the named facility, workshop, testing schedule or listed products. Applicable documents are confirmed for each manufacturing route and project.
QUALITY & MANUFACTURING
Certifications, testing scope and supporting documents are reviewed according to the responsible facility, product category and target market.
PROJECT-SPECIFIC QUALITY INFORMATION
Identify the product, target market, dosage form and documentation category so applicable quality information and outstanding confirmations can be reviewed.